Defence Therapeutics's total assets for Q2 2026 were C$1.37M, a decrease of -17.11% from the previous quarter. DTCFF total liabilities were C$2.59M for the fiscal quarter, a -10.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.